Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
After overspending, assess the cause, cut excess, adjust allocations, and implement a tighter tracking routine to prevent recurrence.
23,645 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Zebra Technologies stock jumped sharply this morning after a solid Q1 2026 report. This article breaks down the numbe...
A multi-million 401K balance can lead to Medicare surcharges if MAGI climbs after retirement. A five-year Roth conver...
When a Materion director trims stake, investors should look beyond the sale. The bigger signal may lie in the company...
Medicare costs hinge on MAGI two years prior, making Roth withdrawals a strategic lever for retirees. New data show m...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
AST SpaceMobile faced a sharp weekly drop after announcing a large convertible debt raise. This article explains why ...
In the first half of 2026, ASML delivered a standout rally as AI-driven demand lifted the semiconductor supply chain....
A 40-year-old who is recently divorced can still reach a comfortable retirement if they commit to disciplined saving ...
Rocket Lab stock is catching strong momentum this week. We break down the key drivers behind the rally, what it means...
Tilray shifted from cannabis focus to a BrewDog partnership in search of diversification. But early UK sales data rai...
Tuesday brought a notable standout in the banking space as JPMorgan Chase topped market momentum. This piece breaks d...